Shah, Chirag http://orcid.org/0000-0002-9295-5554
Whitworth, Pat
Valente, Stephanie
Schwarz, Graham S.
Kruse, Megan
Kohli, Manpreet
Brownson, Kirstyn
Lawson, Laura
Dupree, Beth
Vicini, Frank A.
Article History
Received: 30 May 2022
Accepted: 30 November 2022
First Online: 24 December 2022
Declarations
:
: Chirag Shah- Scientific Consultant ImpediMed, Consultant PreludeX, Consultant Evicore, Consultant Videra Surgical. Frank Vicini- CMO ImpediMed. Stephanie Valente- Oncology Advisory Board/Consultant for ImpediMed, AxoGen, Merit and Pacira. Pat Whitworth- Partner TME LLC, Consultant Impedimed. Graham Schwarz- Consultant Impedimed, Quest Medical Imaging. Megan Kruse declares that she has no conflicts of interest. Manpreet Kohli- Oncology Advisory Board, Impedimed. Kirstyn Brownson- Oncology Advisory Board, Impedimed. Laura Lawson- Oncology Advisory Board, Impedimed. Beth Dupree declares that she has no conflicts of interest.
: This article does not contain any studies with human participants performed by any of the authors.